Operative time, minutes | 207.5 (101.75) |
Ischemia time, minutes | 21.02 (8.38) |
 Cold ischemia time, minutes | 28 (3) |
 Warm ischemia time, minutes | 20.5 (6.38) |
EBL, mL | 100 (237.5) |
Complication | |
 Major, Clavien-Dindo grade 3 or more | 0 (0) |
 Minor, Clavien-Dindo grade 2 or less | 9 (22.5) |
Length of stay, days | 6 (1.75) |
Pathological features | |
 RCC | 23 (57.5) |
  T1a | 16 (69.57) |
  T1b | 5 (21.74) |
  T2 | 2 (8.7) |
 Oncocytoma | 2 (5) |
 Angiomyolipoma | 14 (35) |
 Carcinoid | 1 (2.5) |
Pre-operative | |
 Global eGFR, ml/min/1.73m2 | 94 (27) |
 ERPF of affected kidney, ml/min/1.73m2 | 187.08 (76.11) |
Post-operative | |
 Global eGFR, ml/min/1.73m2 | 82 (31) |
 ERPF of affected kidney, ml/min/1.73m2 | 149.41 (169.45) |
Functional change | |
 Percent change of eGFR | 23.2 (12.51) |
 Absolute change of ERPF | 47.65 (69.39) |
 Percent change of ERPF | 22.16 (34.45) |